arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Apogee Therapeutics, Inc.

APGE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$135.07
Today
as of Oct 22, 16:45 ET
Open
$135.06
High
$135.09
Low
$135.06
Volume
—
Avg Vol
—
Mkt Cap
$10.2B
P/E (TTM)
—
Beta
—
52w High
$135.09
52w Low
$35.39
Div Yield
—
Shares Out
$75M

Recent Press Releases & News last 60 days · 3 items

Sep 9 · 20:58 Insider Monkey
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?
Sep 3 · 13:13 MT Newswires
AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics
Sep 3 · 12:34 PR PR Newswire
AbbVie Completes Acquisition of Apogee Therapeutics

APGE earnings at a glance

The options market is pricing a move of about ±0.2% after the report, a range of roughly $134.82 to $135.32 from today's $135.07. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±4.0% on average; after the most recent report on May 11, 2026 it moved +1.9%. That means options currently expect less movement than APGE has typically delivered. APGE beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 1%. The share price of $135.07 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$35
$135
100% of range
Avg surprise (last 3)
+5.3%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
1%
EM ±0.2% · $135 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.78$-2.96$-2.15$-1.33$-0.51 Actual $-2.51Actual $-3.78Actual $-0.51Actual $-0.64Actual $-0.60Actual $-0.86Actual $-0.95Est $-1.19Actual $-1.13Est $-1.03Actual $-1.11Actual $-1.06Est $-1.12Actual $-1.14 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-86M$-77M$-69M$-60M$-51M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.14 — — — — financials
Mon May 11, 2026Mar/2026 $-1.06 $-1.12 +5.4% -11.6% +1.9% earnings
Tue Sep 30, 2025Sep 2025 $-1.11 — — — — financials
Mon Aug 11, 2025Jun/2025 $-1.13 $-1.03 -9.7% — — earnings
Mon May 12, 2025Mar/2025 $-0.95 $-1.19 +20.2% — +6.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.86 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.60 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.64 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.51 — — — — financials
Fri Jun 30, 2023Jun 2023 $-3.78 — — — — financials
Fri Mar 31, 2023Mar 2023 $-2.51 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-96M$-83M—$-71M$-73M$-63M—$-59M
Net income$-86M$-74M—$-65M$-66M$-55M—$-49M
EPS (diluted)$-1.14$-1.06—$-1.11$-1.13$-0.95—$-0.86

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$106M$452M—$108M$124M$107M—$119M
Inventory————————
Total current assets$992M$1.07B$741M$540M$516M$522M$530M$534M
Total assets$1.34B$1.29B$937M$626M$658M$714M$754M$776M
Long-term debt————————
Total liabilities$141M$38M$33M$40M$38M$41M$37M$42M
Total equity————————

Implied volatility — last 90 days

0%40%80%119%159% Jun 07 — IV 70% · EM ±9.6%Jun 08 — IV 56% · EM ±7.3%Jun 09 — IV 59% · EM ±7.4%Jun 10 — IV 84% · EM ±9.9%Jun 11 — IV 73% · EM ±8.0%Jun 12 — IV 63% · EM ±6.4%Jun 15 — IV 88% · EM ±6.4%Jun 16 — IV 94% · EM ±5.5%Jun 17 — IV 160% · EM ±6.7%Jun 19 — IV 50% · EM ±11.1%Jun 22 — IV 9% · EM ±1.9%Jun 23 — IV 7% · EM ±1.4%Jun 24 — IV 12% · EM ±2.3%Jun 25 — IV 6% · EM ±1.2%Jun 26 — IV 8% · EM ±1.6%Jun 29 — IV 7% · EM ±1.2%Jun 30 — IV 9% · EM ±1.6%Jul 01 — IV 10% · EM ±1.6%Jul 02 — IV 10% · EM ±1.6%Jul 03 — IV 10% · EM ±1.6%Jul 06 — IV 1% · EM ±0.1%Jul 07 — IV 12% · EM ±1.6%Jul 08 — IV 19% · EM ±2.3%Jul 09 — IV 26% · EM ±3.1%Jul 10 — IV 33% · EM ±3.7%Jul 13 — IV 26% · EM ±2.2%Jul 14 — IV 15% · EM ±1.1%Jul 15 — IV 37% · EM ±2.2%Jul 16 — IV 52% · EM ±2.2%Jul 22 — IV 2% · EM ±0.4%Jul 24 — IV 1% · EM ±0.1%Jul 27 — IV 1% · EM ±0.2%Jul 28 — IV 1% · EM ±0.2%Aug 03 — IV 21% · EM ±3.8%Aug 07 — IV 1% · EM ±0.2%Aug 11 — IV 1% · EM ±0.1%Aug 24 — IV 1% · EM ±0.2%Aug 25 — IV 1% · EM ±0.2%Aug 26 — IV 1% · EM ±0.2%Aug 27 — IV 1% · EM ±0.2%Aug 28 — IV 3% · EM ±0.5%Aug 31 — IV 1% · EM ±0.2%Sep 01 — IV 1% · EM ±0.2%Sep 02 — IV 1% · EM ±0.2%

Sector peers

IBRX
ImmunityBio, Inc.
$10.3B $8.31-5.2%
KRYS
Krystal Biotech, Inc.
$9.6B $320.13-1.6%
QGEN
Qiagen N.V.
$9.2B $50.22+2.7%
TECH
Bio-Techne Corp
$11.4B $72.62+0.1%
KYMR
Kymera Therapeutics, Inc.
$9.0B $110.85-2.3%
RGEN
Repligen Corporation
$8.2B $178.71-0.1%

APGE earnings FAQ

What is APGE's expected move for earnings?

Options currently price a move of about ±0.2%, or $0.25 per share either way from $135.07.

How does APGE stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.0%, up 2 times and down 0 times.

What is APGE's implied volatility?

APGE's at-the-money implied volatility is about 1% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in